Abstract
Type 1 regulatory T (Tr1) cells are adaptive regulatory T cells that are induced in the periphery upon chronic exposure to antigen (Ag) in a tolerogenic environment containing interleukin (IL)-10. Tr1 cells are Ag-specific; they produce high levels of IL-10 and TGF-β in the absence of IL-4 and suppress T-cell responses via a cytokine-dependent mechanism. During the last decade, several protocols have been developed to generate Tr1 cell lines in vitro. In this chapter, we outline protocols to generate non-Ag- and Ag-specific Tr1 cell lines and assays used to characterize Tr1 cell phenotype and functions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gavin, M.A., J.P. Rasmussen, J.D. Fontenot, V. Vasta, V.C. Manganiello, J.A. Beavo, and A.Y. Rudensky. 2007. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445:771–775.
Bacchetta, R., E. Gambineri, and M.G. Roncarolo. 2007. Role of regulatory T cells and FOXP3 in human diseases. J Allergy Clin Immunol 120:227–235; quiz 236–227.
Vignali, D.A., L.W. Collison, and C.J. Workman. 2008. How regulatory T cells work. Nat Rev Immunol 8:523–532.
Roncarolo, M.G., S. Gregori, M. Battaglia, R. Bacchetta, K. Fleischhauer, and M.K. Levings. 2006. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 212:28–50.
Bacchetta, R., M. Bigler, J.L. Touraine, R. Parkman, P.A. Tovo, J. Abrams, R. de Waal Malefyt, J.E. de Vries, and M.G. Roncarolo. 1994. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med 179:493–502.
Groux, H., A. O’Garra, M. Bigler, M. Rouleau, S. Antonenko, J.E. de Vries, and M.G. Roncarolo. 1997. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737–742.
Bacchetta, R., C. Sartirana, M.K. Levings, C. Bordignon, S. Narula, and M.G. Roncarolo. 2002. Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines. Eur J Immunol 32:2237–2245.
Vieira, P.L., J.R. Christensen, S. Minaee, E.J. O’Neill, F.J. Barrat, A. Boonstra, T. Barthlott, B. Stockinger, D.C. Wraith, and A. O’Garra. 2004. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J Immunol 172:5986–5993.
Allan, S.E., L. Passerini, R. Bacchetta, N. Crellin, M. Dai, P.C. Orban, S.F. Ziegler, M.G. Roncarolo, and M.K. Levings. 2005. The role of 2 FOXP3 isoforms in the generation of human CD4 Tregs. J Clin Invest 115:3276–3284.
Levings, M.K., S. Gregori, E. Tresoldi, S. Cazzaniga, C. Bonini, and M.G. Roncarolo. 2005. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood 105:1162–1169.
Cobbold, S.P., E. Adams, L. Graca, and H. Waldmann. 2003. Serial analysis of gene expression provides new insights into regulatory T cells. Semin Immunol 15:209–214.
Pot, C., H. Jin, A. Awasthi, S.M. Liu, C.Y. Lai, R. Madan, A.H. Sharpe, C.L. Karp, S.C. Miaw, I.C. Ho, and V.K. Kuchroo. 2009. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J Immunol 183:797–801.
Haringer, B., L. Lozza, B. Steckel, and J. Geginat. 2009. Identification and characterization of IL-10/IFN-gamma-producing effector-like T cells with regulatory function in human blood. J Exp Med 206:1009–1017.
Carpentier, A., F. Conti, F. Stenard, L. Aoudjehane, C. Miroux, P. Podevin, O. Morales, S. Chouzenoux, O. Scatton, H. Groux, C. Auriault, Y. Calmus, V. Pancre, and N. Delhem. 2009. Increased expression of regulatory Tr1 cells in recurrent hepatitis C after liver transplantation. Am J Transplant 9:2102–2112.
Grossman, W.J., J.W. Verbsky, B.L. Tollefsen, C. Kemper, J.P. Atkinson, and T.J. Ley. 2004. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 104:2840–2848.
Levings, M.K., R. Sangregorio, F. Galbiati, S. Squadrone, R. de Waal Malefyt, and M.G. Roncarolo. 2001. IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 166:5530–5539.
Barrat, F.J., D.J. Cua, A. Boonstra, D.F. Richards, C. Crain, H.F. Savelkoul, R. de Waal-Malefyt, R.L. Coffman, C.M. Hawrylowicz, and A. O’Garra. 2002. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 195:603–616.
Kemper, C., A.C. Chan, J.M. Green, K.A. Brett, K.M. Murphy, and J.P. Atkinson. 2003. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421:388–392.
Murugaiyan, G., A. Mittal, R. Lopez-Diego, L.M. Maier, D.E. Anderson, and H.L. Weiner. 2009. IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells. J Immunol 183:2435–2443.
Paccani V., Gregori S, Chini L, Corrente S, Chianca M, Moschese V, Rossi P, Roncarolo MG, Angelini F. 2010. Induction of anergic allergen-specific suppressor T cells using tolerogenic dendritic cells derived from children with allergies to house dust mites. J Allergy Clin Immunol 125:727–36.
Gregori, S., R. Bacchetta, L. Passerini, M.K. Levings, and M.G. Roncarolo. 2007. Isolation, expansion, and characterization of human natural and adaptive regulatory T cells. Methods Mol Biol 380:83–105.
Bacchetta R., Gregori S, Serafini G, Sartirana C, Schultz U, Zino E, Tomiuk S, Janben U, Ponzoni M, Paties CT, Fleischhauer K, Roncarolo MG. 2010. Molecular and functional characterization of alloantigen-specific anergic T cells suitable for cell therapy. Haematologica, in press. Epub ahead of print August 2010.
Morelli, A.E. and A.W. Thomson. 2007. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 7:610–621.
Levings, M.K. and M.G. Roncarolo. 2005. Phenotypic and functional differences between human CD4+CD25+ and type 1 regulatory T cells. Curr Top Microbiol Immunol 293:303–326.
Jonuleit, H., E. Schmitt, M. Stassen, A. Tuettenberg, J. Knop, and A.H. Enk. 2001. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 193:1285–1294.
Gregori S., Tomasoni D, Pacciani V, Scirpoli M, Battaglia M, Magnani Cf, Hauben E, Roncarolo MG. 2010 May 6. [Epub ahead of print]. Differentation of type 1 T regulatory (Tr1) cells by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood.
Foussat, A., F. Cottrez, V. Brun, N. Fournier, J.P. Breittmayer, and H. Groux. 2003. A comparative study between T regulatory type 1 and CD4+CD25+ T cells in the control of inflammation. J Immunol 171:5018–5026.
Cong, Y., C.T. Weaver, A. Lazenby, and C.O. Elson. 2002. Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J Immunol 169:6112–6119.
Zeller, J.C., A. Panoskaltsis-Mortari, W.J. Murphy, F.W. Ruscetti, S. Narula, M.G. Roncarolo, and B.R. Blazar. 1999. Induction of CD4+ T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta. J Immunol 163:3684–3691.
Battaglia, M., A. Stabilini, E. Draghici, B. Migliavacca, S. Gregori, E. Bonifacio, and M.G. Roncarolo. 2006. Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells. Diabetes 55:1571–1580.
Gagliani N., Jofra T, Stabilini A, Valle A, Atkinson M, Roncarolo MG, Battaglia M. 2010. Antigen-specific dependence of Tr1-cell therapy in preclinical models of islet transplant. Diabetes. 59(2):433–9.
Brun, V., H. Bastian, V. Neveu, and A. Foussat. 2009. Clinical grade production of IL-10 producing regulatory Tr1 lymphocytes for cell therapy of chronic inflammatory diseases. Int Immunopharmacol 9:609–613.
Acknowledgments
The authors thank Claudia Sartirana and Chiara Francesca Magnani for technical help. This work was supported by a grant from the Italian Telethon Foundation, Cariplo Foundation, the Italian Association for Cancer Research (Associazione Italiana per la Ricerca sul Cancro, AIRC), and the EU graut to MGR, Riset Consortion (www.risetFp6.org)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press
About this protocol
Cite this protocol
Gregori, S., Roncarolo, M.G., Bacchetta, R. (2010). Methods for In Vitro Generation of Human Type 1 Regulatory T Cells. In: Cuturi, M., Anegon, I. (eds) Suppression and Regulation of Immune Responses. Methods in Molecular Biology, vol 677. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-869-0_3
Download citation
DOI: https://doi.org/10.1007/978-1-60761-869-0_3
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-868-3
Online ISBN: 978-1-60761-869-0
eBook Packages: Springer Protocols